The meeting will bring together hematologists, senior residents, and scientists to discuss new therapeutic standards, real-world treatment experience, geriatric assessment, patient-related outcomes, and quality-of-life issues in lymphoma and immunotherapy.
Detailed information and the registration form are available on the event website.